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Introduction
Mutations in the LMNA gene [MIM 150330] cause a wide variety
of inherited disorders called laminopathies that affect bone, fat,
heart, nervous system, skeletal muscle and skin (reviewed in 
[1, 2]). Lamins are intermediate filament proteins with N- and 
C-terminal regions flanking an -helical rod domain. This structure
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Dunnigan-type familial partial lipodystrophy (FPLD) is a laminopathy characterized by an aberrant fat distribution and a metabolic syn-
drome for which oxidative stress has recently been suggested as one of the disease-causing mechanisms. In a family affected with FPLD,
we identified a heterozygous missense mutation c.1315CT in the LMNA gene leading to the p.R439C substitution. Cultured patient
fibroblasts do not show any prelamin A accumulation and reveal honeycomb-like lamin A/C formations in a significant percentage of
nuclei. The mutation affects a region in the C-terminal globular domain of lamins A and C, different from the FPLD-related hot spot. Here,
the introduction of an extra cysteine allows for the formation of disulphide-mediated lamin A/C oligomers. This oligomerization affects the
interaction properties of the C-terminal domain with DNA as shown by gel retardation assays and causes a DNA-interaction pattern that
is distinct from the classical R482W FPLD mutant. Particularly, whereas the R482W mutation decreases the binding efficiency of the 
C-terminal domain to DNA, the R439C mutation increases it. Electron spin resonance spectroscopy studies show significantly higher 
levels of reactive oxygen species (ROS) upon induction of oxidative stress in R439C patient fibroblasts compared to healthy controls. This
increased sensitivity to oxidative stress seems independent of the oligomerization and enhanced DNA binding typical for R439C, as both
the R439C and R482W mutants show a similar and significant increase in ROS upon induction of oxidative stress by H2O2.
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forms coiled-coil dimers which polymerize into a fibrous network
lining the inner side of the nuclear membrane, and into a more
dispersed network in the nucleoplasm [3, 4]. Lamins play an
essential role in the maintenance of nuclear structural integrity
and in the regulation of chromatin structure and function [5, 6].
Studies on A- and B-type lamins performed under oxidizing 
conditions revealed the capacity to form high molecular weight
complexes through disulphide bond formation [7]. The in vivo
existence of these multimers has been questioned, although
dimers of the 67-kD lamin stabilized by disulphide bonds could
be detected in surf clam (Spisula Solidissima) oocytes [8].
Dunnigan-type familial partial lipodystrophy (FPLD) [MIM
151660] is a laminopathy characterized by wasting of fat in the
extremities and gluteal area starting around puberty, accompanied
by excess fat deposition in the face, neck and often labia majora
[9–11]. In addition, most patients develop a metabolic syndrome
with diabetes mellitus, dyslipidaemia and hypertension [11].
Mutations resulting in classical FPLD usually affect residue R482
and decrease the positive charge of a specific solvent-exposed
surface on the C-terminal Ig-like domain of lamin A/C, which is
conserved in all types of lamins [12]. Multiple disease-causing
mechanisms for laminopathies have been put forward, including
defective structural nuclear and cellular integrity resulting in
increased fragility, aberrant gene expression, defective DNA repair
and prelamin A toxicity [1, 2]. Lately, the notion that oxidative
stress might contribute to the pathogenesis of laminopathies has
been gaining interest [13, 14]. Moreover, the production of reactive
oxygen species (ROS) was increased in fibroblasts from patients
with LMNA mutations causing lipodystrophy and premature aging
disorders [13]. Therefore, mutations introducing a cysteine in
nuclear lamins are of specific interest as the thiol group may be 
a target for oxidation in the presence of ROS, potentially leading to
cystine formation [15].
Here, we studied the functional consequences of the FPLD-
associated heterozygous LMNA missense mutation that affects
nucleotide c.1315CT in exon 7, resulting in an arginine to
cysteine substitution (p.R439C). This mutation has been
reported previously [16] and affects the C-terminal Ig-like
domain of A-type lamins. We examined the impact of this
mutation on the nuclear lamina organization, the structure of
the C-terminal globular domain and the interaction properties
of the R439C mutant C-terminal Ig-like domain with DNA.
Because oxidative stress has been implicated in FPLD, we
investigated ROS levels in R439C patient, R482W patient and
healthy control skin fibroblasts at baseline and upon induction
of oxidative stress by H2O2.
Materials and methods
Patients and cells
Four female patients from a Dutch family presented with an abnormal fat
distribution, pronounced thigh and upper arm musculature and insulin
resistance. Having diagnosed Dunnigan-type partial lipodystrophy, we
examined the LMNA gene for mutations. In all four patients, we identified
a previously reported heterozygous missense mutation c.1315CT
(p.R439C) in exon 7 [16]. Primary skin fibroblast cultures were established
from a skin punch biopsy. R482W skin fibroblasts were obtained from
patient P6, of whom the FPLD phenotype has been described in [17]. All
studies were performed after obtaining informed consent and in accor-
dance with the Helsinki guidelines and appropriate institutional regulations.
Immunocytochemical staining of cultured 
R439C patient fibroblasts
R439C patient fibroblasts were grown on glass cover slips in 12-well culture
plates with DMEM-F12 (Cambrex, Verviers, Belgium), 10% foetal calf 
serum and 1% antibiotics (penicillin-streptomycin; GIBCO-Invitrogen, Cat.
No.15140–148, Leek, The Netherlands). After reaching 80% confluency the
cells were fixed with 4% formaldehyde in phosphate buffered saline (PBS) 
pH 7.4 for 15 min., followed by permeabilization in 0.1% Triton X-100 for 10 min.
at room temperature (RT). For staining with the LN43 antibody, cells were fixed
in methanol at –20C for 10 min. Primary antibodies (see below) diluted in PBS
with 3% bovine serum albumine (BSA) were applied onto the cells for 1 hr at
RT. After washing in PBS, secondary antibodies were applied for 1 hr at RT.
Secondary antibodies used are fluorescein isothiocyante (FITC)-conjugated
rabbit anti-mouse Ig (1:100, DAKO, Heverlee, Belgium), FITC-conjugated
swine anti-rabbit Ig (1:80, DAKO) or FITC-conjugated rabbit anti-goat Ig (1:50,
DAKO). Secondary antibodies were diluted in PBS pH 7.4 containing 3% BSA.
After three final washing steps (each 5 min.) in PBS, slides were mounted in
90% glycerol, 0.02 M TRIS–HCl (pH 8.0), 0.8% NaN3 and 2% 1,4-di-azobicy-
clo-(2,2,2)-octane (DABCO; Merck, Haarlem, The Netherlands) containing 
1 mg/ml propidium iodide. Hereafter, the samples were analysed by confocal
laser scanning microscopy. The settings of the MRC600 confocal microscope
(Bio-Rad Laboratories, Hemel Hempstead, Hertfordshire, UK) have been
described earlier [18].
Primary antibodies used for immunofluorescence
studies:
(1) Jol-2 (mouse monoclonal IgG1) was kindly provided by Dr. C.
Hutchison (Durham, UK). The antibody reacts with an epitope (amino
acids 464–572) in the C-terminal domain of lamins A, A10 and C
[19]. Dilution used for immunocytochemistry: 1/20, dilution used for
immunoblotting: 1/1000. 
(2) 133A2 (mouse monoclonal IgG3) was a kind gift from Dr. Y. Raymond
(Montreal, Canada) and is distributed by MUbio Products BV
(Maastricht, The Netherlands). It recognizes lamin A and A10, react-
ing with the epitope consisting of amino acids 598–611 [20]. Dilution
used for immunocytochemistry: 1/100.
(3) RalC (MUbio Products BV) is an affinity purified rabbit polyclonal antibody
directed against the C-terminal sequence VSGSRR (position 567–572) of
human lamin C [21]. Dilution used for immunocytochemistry: 1/20.
(4) 119D5-F1 (mouse monoclonal IgG1) (MUbio Products BV) directed
against an epitope located C-terminal of residue 231 in lamin B1 [20,
22, 23]. Dilution used for immunocytochemistry: 1/100.
(5) Lamin B1 is an affinity-purified rabbit polyclonal antibody to lamin B1,
kindly provided by Dr J.C. Courvalin (INSERM, Paris, France) [24].
Dilution used for immunocytochemistry: 1/100.
(6) LN43 (mouse monoclonal IgG1) (MUbio Products BV), recognizes
lamin B2 and does not cross react with lamin B1 or A-type lamins [25].
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The antibody was kindly provided by Dr. E.B. Lane (Dundee, UK). LN43
was used as undiluted culture supernatant or diluted 1/5 in immuno-
cytochemistry.
(7) NCL-emerin (mouse monoclonal IgG1) (clone 4G5; Novocastra,
Newcastle, UK) directed against the 222 amino acid N-terminal part of the
emerin protein [26, 27]. Dilution used for immunocytochemistry: 1/50.
(8) -Prelamin A (PA), a polyclonal rabbit antibody kindly provided by Dr.
M. Sinensky, and directed against the 15 amino acids of prelamin A
that are proteolytically removed during the farnesylation-dependent
processing step [28]. Dilution used for immunocytochemistry: 1/200,
dilution used for immunoblotting: 1/250.
(9) Lamin A (C-20), a polyclonal goat antibody (sc-6214; Santa Cruz
Biotechnology, Santa Cruz, CA, USA) directed against a peptide map-
ping at the C-terminus of both lamin A and prelamin A [29]. Dilution
used for immunocytochemistry: 1/50.
Lovastatin treatment of cultured R439C patient
fibroblasts
R439C fibroblasts (passage 7) were cultured up to 50% confluence on glass
cover slips in 12-well culture plates with DMEM-F12 (Cambrex), 10% foetal
calf serum and antibiotics (penicillin-streptomycin; GIBCO-Invitrogen) in a
1:100 dilution. The farnesylation inhibitor lovastatin (Merck) was added to
the culture medium at a 40 M concentration, as described earlier [18].
After 18 hrs the cells were fixed with 4% formaldehyde in PBS for 15 min.
and stained with the -PA antibody as described above.
Gel electrophoresis and immunoblotting
One-dimensional SDS-polyacrylamide gel electrophoresis (Bio-Rad Lab-
oratories) was performed as described by Laemmli [30]. We used
Coomassie Brilliant Blue staining to assess the amount of protein loaded
onto the gel. Gels were run on the Mini-Protean II system from Bio-Rad Lab-
oratories at 100 V for 1 hr or 1 hr 30 min. Proteins were blotted using a
Mini Trans-Blot cell (Bio-Rad Laboratories) onto nitrocellulose membranes
(BA85, Schleicher and Schüll, Dassel, Germany) during 60 min. at 100 V,
in a buffer containing 192 mM glycine (Bio-Rad Laboratories), 
25 mM TRIS (Bio-Rad Laboratories), 20% methanol (Sigma, Moerdijk, The
Netherlands) and 0.02% SDS (Bio-Rad Laboratories), essentially as
described by Towbin [31]. The membranes were pre-incubated in blocking
solution (PBS/0.5% Triton X-100 with 5% non-fat dry milk [Vreugdenhil
B.V., Voorthuizen, The Netherlands]) followed by 1 hr incubation with anti-
bodies X67 (dilution 1:250, mouse monoclonal IgG1) kindly provided by
Dr. G. Krohne (Würzburg, Germany) recognizing amino acids 1–28 at the
N-terminus of lamins A, A10 and C, Jol-2 (specified above) or -PA
(specified above). As secondary antibody, peroxidase-conjugated rabbit
anti-mouse Ig (DAKO) (dilution 1/10,000) or peroxidase-conjugated swine
anti-rabbit Ig (DAKO) (dilution 1/10,000) was used. Peroxidase activity was
detected by chemiluminescence (Pierce, Rockford, IL, USA), visualized on
RX Fuji medical X-ray films (Fuji, Tokyo, Japan).
Recombinant globular domain protein preparation
The cDNA plasmid encoding the wild-type A-type lamin C-terminal domain
(residues 411–553) [12] served as a basis to generate the R439C mutant
peptide using the Transformer Site-Directed Mutagenesis Kit (Clontech
Laboratories, Mountain View, CA, USA) following the manufacturer’s
instructions (primer sequences used are available upon request). The wild-
type, as well as mutant R482W [32] and R439C A-type lamin C-terminal
domains (residues 411–553) were cloned into plasmid pGEX-4T-1
(Amersham Pharmacia Biotech, Piscataway, NJ, USA) that encodes glu-
tathione-S-transferase (GST) and a thrombin cleavage site between the
lamin protein and GST. The construct was expressed in E. coli strain BL21
Star (DE3) (Invitrogen, Groningen, The Netherlands). The fusion protein
was purified using glutathione sepharose 4B (Amersham Pharmacia
Biotech) and cleaved using thrombin protease.
NMR spectroscopy
For nuclear magnetic resonance (NMR) spectroscopy, samples contained
0.5 mM protein dissolved in 20 mM TRIS-HCl buffer (pH 6.3), 1 mM dithio-
threitol (DTT), 1 mM ethylenediaminetetraacetic acid (EDTA) and 0.1 mM
NaN3, while 3-(trimethylsilyl) [2,2,3,3–2H4] propionate (TSP) was added
as a chemical shift reference. All experiments were performed at 20C on
a Bruker DRX-600 spectrometer (Fällanden, Switzerland) and spectra were
processed with the program Xwinnmr.
Circular dichroism
For the circular dichroism studies the protein concentration used was 5 M
in a buffer of 20 mM TRIS-HCl (pH 6.3) containing 0.1 mM DTT. The C-ter-
minal domain of the R439C A-type lamin mutant was analysed by circular
dichroism using a Jobin-Ivon CD6 spectropolarimeter (Longjumeau,
France). Spectra were recorded between 190 and 250 nm on a 1 ml protein
sample (optical length: 1cm) at temperatures varying from 10C to 90C.
Dimerization/oligomerization study
For the dimerization/oligomerization studies the wild-type, R439C or
R482W mutant A-type lamin globular domains were diluted to 50 M in 
10 mM Tris-HCl (pH 8.0), 1 mM EDTA and 1 mM 4-(2-aminoethyl)-benzene-
sulfonyl fluoride containing 100 mM NaCl and 0.1% Triton X-100, and
incubated at either 4C or 37C. At different time-points of the dimeriza-
tion/oligomerization kinetics study, proteins were solubilized in one volume
of two-times concentrated SDS-sample buffer (62.5 mM Tris-HCl pH 6.8,
2.0% SDS, 10% glycerol and 0.05% Bromophenol Blue) with or without
100 mM DTT and analysed by SDS-gel electrophoresis.
Gel retardation assay
DNA preparation
The 357 bp DNA fragment was obtained from a BamHI digest of the plas-
mid pUC357.4 [33]. The 67bp DNA fragment was obtained from the DraI
and DpnI double digest of the 357bp DNA fragment. Dephosphorylation of
DNA fragments and 5-end labelling with 32P-ATP and T4 polynucleotide
kinase were performed according to standard protocols [34].
Protein–DNA interactions
Protein diluted at the indicated concentrations in 10 mM TRIS-HCl (pH 8.0),
1 mM EDTA and 1 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride containing
100 mM NaCl and 0.1% Triton X-100 were incubated with radioactive DNA
fragments at either 4C, 8C or RT for 3 or 16 hrs as indicated in the figure
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legends. Protein–DNA complexes were analysed on 4% polyacrylamide gels
at an acrylamide/bisacrylamide ratio of 29/1 (w/w) in 12.5 mM TRIS-HCl 
(pH 8.4), 95 mM glycine, and 0.5 mM EDTA. After a 1 hr pre-electrophoresis,
samples were loaded and resolved at 80 V by a 45 min. to 2 hrs 30 min elec-
trophoresis – depending on the size of the DNA fragment – at 4C except for
the 67bp electrophoresis that was performed at RT. DNA retardation was
detected by autoradiography of the dried polyacrylamide gel kept at –80C,
using Biomax MR film (Kodak, Paris, France) and an intensifying screen.
Electron spin resonance (ESR) spectroscopy
Solutions of the spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO, Sigma)
were purified as described before [35]. Three days prior to the ESR spec-
troscopy R439C patient (passages 10–14), R482W patient (passage 13) and
control (normal human dermal fibroblasts (NHDF)-, passages 10–14)
fibroblasts were plated in 45 mm cell culture dishes and grown to 80% con-
fluence at the start of the experiments. For each cell line, three different cell
culture dishes were counted to determine the mean cell number. The remain-
ing dishes were washed twice with Hank’s balanced salt solution (HBSS,
Invitrogen), followed by incubation of the cells in 1 ml 50 mM DMPO in HBSS
in a CO2 incubator at 37C for 30 min. Subsequently, 200 M H2O2 was added
for another 30 min. in order to assess ROS production under oxidative stress.
The H2O2-treated and control cells were harvested by scraping, centrifuged
for 3 min. at 3000 rpm in an Eppendorf centrifuge, and re-suspended in a final
volume of 200 l. For each sample a 100 l glass capillary (Brand, Wertheim,
Germany) was filled with the suspension and sealed. The capillary was imme-
diately placed in ER 4119HS high sensitivity resonator placed in X band
Bruker EMX 1273 spectrometer and spectra were recorded at RT. The instru-
mental conditions for the recorded spectra and the quantification of the
DMPO-hydroxy (OH) signal in the spectra performed by peak surface meas-
urements using the WIN-EPR spectrum manipulation program, were done as
described before [35]. All experiments were performed in triplicate and statis-
tical analysis was performed with an unpaired two-tailed t-test with a 95%
confidence interval.
Results
Organization of the nuclear lamina in R439C 
skin fibroblasts
Cultured R439C skin fibroblasts were used at passage 3 for
immunocytochemical lamin analyses (Fig. 1) and compared to 
normal NHDF- skin fibroblasts (data not shown). Several nuclei in
the R439C mutant were irregularly shaped. Nuclear blebbing was
found in 6.5% of all patient fibroblasts, while honeycomb struc-
tures were encountered in about 10% of the nuclei (Fig. 1A and B).
Donut-shaped nuclei could be detected in a small percentage of
cells (1%). In contrast, human control fibroblasts (NHDF-, 
passage 5) showed nuclear blebbing and honeycomb figures in
about 2% and 3%, respectively (data not shown). A-type lamins
(Fig. 1A–C) as well as emerin (Fig. 1D) were normally expressed at
the nuclear lamina of the R439C mutant. However, in the nuclear
protrusions lamin B1 (Fig. 1E) was absent and lamin B2 (Fig. 1F)
expression reduced. Prelamin A expression could not be detected
with the -PA antibody, directed against the 15 amino acids of
prelamin A that are proteolytically removed during processing 
(Fig. 1H and J). With the lamin A (C-20) antibody, used by Capanni
et al. [29] and Caron et al. [13] to show the accumulation of
prelamin A in fibroblasts of patients with lipodystrophy-featured
laminopathies such as FPLD and MAD, we did find a nuclear staining
pattern (Fig. 1K). However, because the lamin A (C-20) antibody
can cross-react with mature lamin A and farnesylation inhibition by
lovastatin treatment did result in the positive identification of
prelamin A by the -PA antibody at the lamina and in nuclear enve-
lope invaginations (Fig. 1I–I’), we conclude that the untreated
R439C mutant does not accumulate prelamin A (see also Fig. 1G).
Expression levels of A-type lamins in R439C 
skin fibroblasts
R439C fibroblasts (Fig. 1G, lane 2) and the human control fibrob-
last cell line NHDF- (Fig. 1G, lane 1) were used to assess and
compare expression levels of A-type lamins by means of
immunoblotting. Actin was used as a loading control. With an
antibody recognizing the C-terminal globular domain of A-type
lamins (Jol-2; Fig. 1G, top) lamins A and C were positively identi-
fied, next to a third band beneath lamin C, representing a 46-kD
proteolytic fragment of lamins A/C [36] (Fig. 1G, asterisk). No sig-
nificant differences in expression levels between the normal and
mutant lamins were observed. Also, the lamin A/C ratio seemed to
be largely unaltered. These findings were confirmed using a lamin
A/C antibody recognizing the N-terminal region of A-type lamins
(X67; Fig. 1G, middle). Prelamin A accumulation was assessed by
the -PA antibody in R439C fibroblasts and in fibroblasts from a
patient with restrictive dermopathy (RD) caused by a homozygous
c.1085_1086insT mutation in ZMPSTE24, which abolishes the
processing of prelamin A (Fig. 1G, bottom). Prelamin A could not
be detected in R439C fibroblasts, whereas the RD patient showed
a distinct band indicating prelamin A accumulation.
Position of the affected R439 residue 
in the Ig-like C-terminal globular domain
Analysis of the three-dimensional structure of the A-type lamin 
C-terminal globular domain, as determined by NMR spectroscopy
[12] and X-ray crystallography [37], shows that the affected
residue R439 is located in a loop (residues 436 to 441) connect-
ing 	-strand 1 and 	-strand 2 (Fig. 2A) [12]. C522, the only cys-
teine present in the native C-terminal globular domain, is situated
on the opposite site of the globular domain (Fig. 2A–C). R439 is
solvent accessible, similar to other residues of the C-terminal
globular domain mutated in FPLD, though located more than 10 Å
away from these residues (Fig. 2B and C). The region commonly
affected in FPLD (e.g. residues R482, K486 and G465) corresponds
to a surface highly conserved in A- and B-type lamins, as illus-
trated in Fig. 2B and C by the blue colour. R439 is only 
conserved in A-type lamins.
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Stability and structure of the R439C mutant Ig-like
C-terminal globular domain
The evolution of the circular dichroism spectrum of the E. coli-
 produced R439C mutant A-type lamin C-terminal globular domain
(residues 411–553) as a function of temperature shows that the
denaturation temperature of the R439C mutant is 58C (Figure
S1A and B). This value is close to the denaturation temperature of
the wild-type C-terminal globular domain (62C) (Figure S1B).
Analysis of the NMR proton spectra of the wild-type and 
R439C mutant peptides revealed no significant differences in the 
Fig. 1 Immunofluorescence staining patterns of A-and B-type lamins in single confocal sections (A–F) and in Z-stack projections (H-K) of cultured
R439C fibroblasts. Lamin A/C staining with antibody Jol-2 (A) and lamin A staining with antibody 133A2 (B) reveals the presence of honeycomb fig-
ures in the nuclear lattice (arrows). Lamin C staining with antibody RalC reveals intra-nuclear tubular structures (C). Emerin staining with antibody NCL-
Emerin shows a slightly increased expression of emerin in the lamina lining the bleb (D). Staining with antibody 119D5-F1 reveals the absence of lamin
B1 in the lamina lining the protrusion filled with chromatin (E, arrow). Note the donut-shaped nucleus. Staining with antibody LN43 shows a reduced
expression of lamin B2 in the lamina lining the bleb (F, arrow). Prelamin A expression could not be detected with the -PA antibody (H, J), whereas the
lamin A (C-20) antibody showed immunostaining in the lamina and nucleoplasm (K). Imaging of (J) and (K) was performed with identical recording set-
tings and without image restoration. Farnesylation inhibition by lovastatin resulted in the accumulation of prelamin A at the lamina and in nuclear enve-
lope invaginations, as detected by the -PA antibody (I). The orthogonal view (I’) shows these membrane invaginations more clearly. Nuclei counter-
stained with propidium iodide are shown in the right panels of (E), and (H)–(K). Scale bars represent 10 m. Immunoblotting for A-type lamins in human
control fibroblasts (NHDF-) and R439C patient fibroblasts is presented (G). Actin was used as a control for protein loading. With the Jol-2 antibody
(top) and the X67 antibody (middle) protein bands corresponding to lamins A and C could be detected. Control and patient cells showed no significant
quantitative or qualitative differences in A-type lamins. *Additional band showing the 46-kD proteolytic fragment containing the C-terminal end of lamins
A/C. Prelamin A expression was assessed by the -PA antibody in R439C fibroblasts and fibroblasts from a patient with restrictive dermopathy (RD)
caused by a homozygous c.1085_1086insT mutation in ZMPSTE24, which abolishes the processing of prelamin A (bottom). Prelamin A could not be
found in R439C cells, whereas the RD patient showed a distinct band on the gel indicating prelamin A accumulation.
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three-dimensional structures of both wild-type and mutant 
C- terminal globular domains (Figure S1C).
Oligomerization of the R439C mutant Ig-like 
C-terminal globular domain
Gel electrophoresis shows that the wild-type and R482W Ig-
like peptides are both able to form dimers under non-reducing
conditions, and do not oligomerize further (Fig. 3A–C). In con-
trast, the R439C mutant Ig-like C-terminal globular domain
demonstrates extensive oligomerization at 4C and at 37C
under non-reducing conditions, represented by multiple bands
with decreasing mobility in the gel (Fig. 3B, lanes 3 and 4).
Time-dependent kinetics at 4C are provided for both the wild-
type (Fig. 3D) and R439C mutant (Fig. 3E) Ig-like peptides and
underscore the oligomerization capacity of R439C. Under
reducing conditions, no dimerization of the wild-type lamin A/C
(Fig. 3A, lane 2 and Fig. 3D, lane 1) or oligomerization of the
R439C mutant peptide (Fig. 3E, lane 1) was detectable.
Therefore, dimerization is most likely mediated by inter-molec-
ular disulphide bond formation implicating residue C522 for
the wild-type and R482W Ig-like peptide, whereas oligomeriza-
tion of the mutant R439C peptide is likely mediated by intra-
and inter-molecular disulphide-bond formation involving both
residues C522 and C439.
DNA interaction studies with the R439C mutant
Ig-like C-terminal globular domain
Gel retardation assays were performed to compare the DNA bind-
ing capacity of the mutant R439C and R482W Ig-like lamin A/C
C-terminal globular domains to that of the wild-type protein. The
monomers of either mutant, like their wild-type counterpart, 
do not bind DNA (data not shown) [32]. After dimerization/
oligomerization, both wild-type and mutant Ig-like domains bind
naked DNA, but the gel retardation profiles are different. Figure 4A
illustrates that after 2 hrs 30 min. of dimerization at 37C, the wild-
type Ig-like domain incubated at RT with DNA forms at least four
distinct complexes with DNA visible as discrete bands on the gel.
At the highest peptide concentrations, three to four dimers are
bound to the DNA fragment and 32 molar excess of peptide is 
sufficient to bind all DNA (Fig. 4A, lane 4). For the R439C mutant,
all steps were performed at 4C to minimize the formation of large
oligomers with temperature (Fig. 3B, lane 4) that would impede
the electrophoretic resolution of the DNA/Ig-peptide complexes.
The DNA/Ig-peptide complexes formed with the R439C mutant
peptide, previously oligomerized at 4C for 24 hrs, migrate as a
smear (Fig. 4C) instead of showing discrete bands as obtained
with the wild-type Ig-like domain under identical conditions 
(Fig. 4B). At the highest peptide concentration, the mutant pep-
tide/DNA complexes largely fail to enter the gel (Fig. 4C, lane 5).
Fig. 2 Localization of residue R439 on the solvent exposed surface of the A-type lamin Ig-like C-terminal globular domain. (A) Backbone structure of
the Ig-like C-terminal globular domain of human lamin A/C (residues 411–553), as determined by NMR. The affected residue R439 is located in a loop
connecting 	1- and 	2-strands. Residue C522, the only cysteine present in the native C-terminal globular domain of A-type lamins, is found on the oppo-
site side of the 	-sandwich. The R435 residue, previously associated with isolated dilated cardiomyopathy [40] when mutated to a cysteine and now
also found by us in FPLD (A. van den Wijngaard, unpublished data), is localized on the same solvent-accessible surface near R439. The R482, K486
and G465 residues involved in classical FPLD are also depicted. (B, C) Three-dimensional representation of the Ig-like C-terminal domain of A-type
lamins. The colour code indicates the degree of conservation of each residue within the lamin family, in a spectrum from dark blue for highly conserved
residues to red for less conserved residues. Residues R435 (in cyan) and R439 (in yellow) are not conserved between A- and B-type lamins, though
mostly conserved between A-type lamins. Residues R435 and R439 are located at more than 10 Å from a highly conserved positively charged region
affected in previously described FPLD. (B) This view is centred on the conserved and thus blue coloured region affected in previously described FPLD.
Residues R435 and R439 lay behind the displayed surface as indicated by the dotted arrows. (C) The orientation of the C-terminal globular domain 
corresponds to that of Figure 3B rotated by 90 around the vertical axis, revealing the position of the R435 and R439 residues.
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Fig. 3 Oligomerization of the recombinant R439C mutant A-type lamin C-terminal Ig-like domain. (A) SDS-polyacrylamide gel electrophoretic analysis
of the wild-type lamin A/C Ig-like domain (Ig WT; residues 411–553). Coomassie Brilliant Blue staining of gels in which the wild-type lamin A/C peptide
was resolved under non-reducing conditions (lane 1) and reducing conditions (lane 2) after incubation at 4C for 16 hrs. Under reducing conditions a
single 18-kD band occurs corresponding to the monomer, whereas under non-reducing conditions dimerization of the Ig-like domain is observed at 
36 kD. (B) SDS-polyacrylamide gel electrophoretic analysis of dimerization of the wild-type lamin A/C (Ig WT) and oligomerization of the R439C lamin A/C
mutant (Ig R439C) Ig-fold domains (residues 411–553). Coomassie Brilliant Blue staining of the gel in which Ig WT and Ig R439C peptides were
resolved under non-reducing conditions. Lanes 1 and 3 correspond to incubation at 4C for 40 hrs of Ig WT and Ig R439C peptides, respectively. Lanes
2 and 4 correspond to incubation at 37C for 16 hrs of Ig WT and Ig R439C peptides, respectively. Dimerization of Ig WT and extensive oligomerization
of Ig R439C are clearly observed. (C) SDS-polyacrylamide gel electrophoretic analysis of dimerization of the wild-type lamin A/C (Ig WT) and R482W
lamin A/C mutant (Ig R482W) Ig-like domains (residues 411–553). Lanes 1 and 3 show Coomassie Brilliant Blue staining of the gel in which Ig WT and
Ig R482W peptides, respectively, were resolved under non-reducing conditions at 0 hr. Lanes 2 and 4 correspond to incubation at 37C for 3 hrs under
non-reducing conditions for Ig WT and Ig R482W, respectively. Dimerization of both peptides is almost complete, while no further oligomerization is
seen. (D–E) SDS-polyacrylamide gel electrophoretic analysis of the time dependent dimerization/oligomerization at 4C of the wild-type (Ig WT; D) and
R439C mutant (Ig R439C; E) lamin A/C Ig-like domain (residues 411–553). Coomassie Brilliant Blue staining of the gel in which peptides were resolved
under non-reducing conditions. When Ig WT or Ig R439C was resolved under reducing conditions with 100 mM DTT (lane 1), dimeriza-
tion/oligomerization did not take place. Lanes 2 to 7 reveal the multimers formed during incubation at 4C after 0, 16, 24, 40, 48 and 64/62 hrs, respec-
tively. The lower arrowhead refers to the monomer, the upper to the dimer.
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The gel retardation assay for the R482W mutant (Fig. 4E) showed
that this mutant interacts to a limited extent with DNA as com-
pared to the wild-type (Fig. 4D) under the same conditions,
although still forming stable protein–DNA complexes, as indicated
by the distinct bands on the gel (Fig. 4E, lanes 2–4). The reduced
affinity results from the absence of a proper DNA-interaction site
in the R482W mutant Ig-domain, as previously described [32].
The most obvious differences between the two mutants in their
interaction with DNA are the presence of similar DNA-protein
bands in the wild-type and R482W mutant, whereas the R439C
only shows a smear and the fact that the R439C mutant shows an
increased DNA-binding efficiency saturating all DNA at the highest
protein concentrations, whereas the R482W mutant peptide
exhibits a decreased binding affinity for DNA. The smear observed
for the R439C mutant reflects the heterogeneity of the pro-
tein–DNA interactions, resulting from a great variety of intra- and
inter-molecular disulphide-bond mediated oligomeric complexes
with undefined affinities for DNA, which migrate all over the gel.
ESR spectroscopy studies in patient skin
 fibroblasts
Because of two previous reports indicating higher levels of oxida-
tive stress in laminopathies and especially in lipodystrophy-
 featured laminopathies [13, 14], we investigated the level of ROS
by measuring DMPO-trapped oxygen radicals in R439C patient,
R482W patient and control (NHDF-) fibroblasts. ESR measure-
ments showed a similar level of ROS in R439C and NHDF- fibrob-
lasts under normal cell culture conditions (P-value 
 0.2935; 
Fig. 5A, B and E). However, upon induction of oxidative stress by
application of H2O2, the R439C patient fibroblasts showed signifi-
cantly higher levels of ROS compared to healthy control NHDF-
fibroblasts under the same conditions (P-value 
 0.0053; 
Fig. 5C–E). Interestingly, R439C patient fibroblasts showed signifi-
cantly less ROS levels compared to R482W patient fibroblasts
under normal cell culture conditions (P-value 
 0.023; Fig. 5F).
However, upon induction of oxidative stress by application of H2O2,
the R439C patient fibroblasts showed similar levels of ROS com-
pared to the R482W patient cells (P-value 
 0.1874; Fig. 5F).
Discussion
Cellular damage due to oxidative stress is increasingly seen as one
of the possible disease-causing mechanisms in laminopathies 
[13, 14]. In particular, high levels of ROS, mostly produced by the
mitochondria, were encountered in fibroblasts from patients with an
LMNA-associated lipodystrophy [13]. Moreover, Caron et al. showed
a reduced expression level of mitochondrial respiratory chain pro-
teins in subcutaneous adipose tissue from a patient with R439C-
associated FPLD [13]. Here, we studied ROS production in skin
fibroblasts from our patient with R439C-associated FPLD. Because
cysteine residues are a well-known target for oxidation [15], we sug-
gested that the R439C mutant lamin A/C gives rise to increased
disulphide-mediated complex formation upon oxidative stress.
Cultured R439C skin fibroblasts showed nuclear abnormalities
also reported in other patients with FPLD, such as blebbing and
honeycomb-structures [38]. However, in contrast to Caron et al.
showing prelamin A accumulation in R439C adipose tissue [13],
we could not detect any prelamin A accumulation in the R439C
skin fibroblasts.
The R439C mutation does not significantly modify the three-
dimensional structure or the thermal stability of the A-type lamin
Ig-like C-terminal globular domain. This is consistent with the
structural characterization of other FPLD mutations [12]. However,
introduction of this additional cysteine provokes extensive
oligomerization of the A-type lamin globular domain. The wild-
type globular domain contains only one cysteine residue at amino
acid position 522, thought to be required for inter-molecular
dimerization between two oppositely directed Ig-like C-terminal
Fig. 4 Interaction of the R439C mutant A-type lamin Ig-peptide (residues 411–553) with double-stranded DNA as compared to that of the classical
R482W FPLD mutant. (A) Binding of the wild-type lamin A/C dimer to DNA for 3 hrs at RT. The 357 bp DNA fragment at a concentration of 11 nM in
100 mM NaCl was incubated with increasing concentrations of the wild-type lamin A/C Ig-fold (Ig WT; residues 411–553) previously dimerized at 37C
for 2 hrs 30 min. Incubation was performed in the presence of an 8-fold (lane 2), 16-fold (lane 3), 32-fold (lane 4) and 64-fold (lane 5) molar excess
of the peptide. Lane 1 indicates the mobility of naked DNA. (B and C) Comparison of wild-type and R439C mutant lamin A/C multimer binding to DNA
for 3 hrs at 4C. The 357 bp DNA fragment at a concentration of 11 nM in 100 mM NaCl was incubated with increasing concentrations of the wild-type
(Ig WT) and R439C mutant (Ig R439C) Ig-like peptide (residues 411–553) previously dimerized or oligomerized at 4C for 24 hrs. Incubations were per-
formed in the presence of an 8-fold (lane 2), 16-fold (lane 3), 32-fold (lane 4) and 64-fold (lane 5) molar excess of the peptides. Lane 1 indicates the
mobility of naked DNA. Stable DNA-peptide complexes are formed with the highest concentrations of Ig WT dimerized at 4C (arrowheads). The Ig
R439C oligomers also bind to DNA. However, the DNA-peptide complexes migrate as a smear on the gel (lanes 2 to 4) revealing at once the plurality
of the DNA binding sites. At higher peptide concentrations, DNA-peptide complexes failed to enter the gel due to enhanced protein–protein interactions.
(D and E) Comparison of binding of the wild-type (Ig WT) and R482W mutant (Ig R482W) Ig-like peptide (residues 411–553) dimers to DNA for 16 hrs
at 8C. The 67bp DNA fragment at a 14 nM concentration in 100 mM NaCl was incubated with increasing concentrations of Ig WT or Ig R482W, both
previously dimerized at 30C for 2 hrs 30 min. Incubation was performed in the presence of a 32-fold (lane 2), 64-fold (lane 3) or 128-fold (lane 4)
molar excess of the peptides. Lane 1 indicates the mobility of naked DNA. For the R482W mutant, stable protein–DNA complexes could be detected as
discrete bands (lanes 2–4), however, with a decreased affinity for DNA as compared to the Ig WT under these conditions.
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Fig. 5 ESR spectroscopic measurements of DMPO-trapped oxygen radicals in patient and control fibroblasts before and after induction of oxidative
stress. The DMPO-OH signals (indicated with *) in the ESR spectra of human control fibroblasts (A, NHDF-) and R439C patient fibroblasts (B, R439C)
were similar under normal conditions. However, upon induction of oxidative stress with H2O2, the R439C patient fibroblasts (D, R439C  H2O2) showed
significantly higher levels of ROS compared to healthy control fibroblasts under the same conditions (C, NHDF-  H2O2). The quantitative analysis of
ROS production levels in control and R439C patient cells before and after induction of oxidative stress is presented in panel E. Interestingly, R439C
fibroblasts showed significantly less ROS compared to R482W fibroblasts under normal conditions (F, R439C and R482W). However, upon induction
of oxidative stress by H2O2, both mutants showed similar levels of ROS (F, R439C  H2O2 and R482W  H2O2).
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globular domains [32]. In the absence of a reducing agent, the
mutated Ig-like domain, now containing two cysteines, formed
large size oligomers likely dependent on both intra- and inter-
molecular disulphide bond formation, implicating both the C522
and C439 amino acid residues, whereas the wild-type Ig-fold only
formed a dimer.
As dimerization of the A-type lamin Ig-like C-terminal globular
domain (residues 411–553) through C522 allows the formation of
an Ig-like dimer with DNA binding capacity [32], we compared in vitro
DNA binding of the R439C mutant Ig domain to wild-type and 
the R482W mutant. We showed that the R439C mutation modifies
the interaction with DNA. Residue R439 is not situated in the
regions thought to be involved in the interaction between the 
Ig-like domain and DNA, i.e. the region holding the nuclear local-
ization signal and a large positively charged area centred around
residue R482 [32]. Thus, the mutation probably does not interfere
directly with the lamin–DNA interaction, as shown here for R482W
and previously also reported for R482Q [32]. The gel retardation
assay with the R482W mutant globular domain shows a decreased
binding affinity of the peptide to DNA, although distinct bands can
still be observed. In the case of the R439C mutant, the DNA-bind-
ing capacity is significantly larger compared to both the wild-type
and R482W mutant, most likely due to the presence of multiple
disulphide bonds that are critical for DNA binding [32]. This
increase in DNA binding could potentially alter the functionality of
DNA-repair foci when they evolve upon DNA damage leading to
defective DNA repair, also reported in other laminopathies [39].
Based on the finding of high levels of ROS in fibroblasts from
patients with an LMNA-associated lipodystrophy [13], we per-
formed ESR spectroscopy to evaluate the ROS levels by measuring
oxygen radicals in fibroblasts from our R439C patient, a R482W
patient and a healthy control. We found a similar level of ROS in the
R439C fibroblasts compared to healthy control fibroblasts under
normal conditions. However, upon induction of oxidative stress by
H2O2, the R439C patient fibroblasts showed significantly higher
 levels of ROS compared to healthy control cells, indicating an
increased ROS generation or decreased buffering capacity in
response to oxidative stress. In order to assess a role for oligomer-
ization and enhanced DNA binding in the increased H2O2 sensitivity
of R439C, we compared the ROS levels in R439C and R482W
patient skin fibroblasts. Interestingly, ESR spectroscopy showed
significantly less ROS in R439C skin fibroblasts compared to
R482W patient fibroblasts under normal conditions. Because cys-
teines can react with ROS to form reversible oxidative thiol modifi-
cations [15], the additional R439C cysteine could potentially buffer
the earlier reported increase in mitochondrial ROS production
observed in FPLD [13]. However, upon induction of oxidative stress
by H2O2, both mutants showed a similar and significant increase in
ROS and thus, share a similar sensitivity to oxidative stress by H2O2.
Hence, we conclude that the increased sensitivity to oxidative stress
in R439C skin fibroblasts is most likely independent of the
oligomerization and enhanced DNA binding typical for R439C.
In conclusion, we show that the R439C mutation causes
oligomerization of the C-terminal globular domain of lamins A and
C, which increases its binding affinity for DNA. From this perspec-
tive, the R439C mutant differs substantially from the typical R482W
FPLD mutant, which lacks an oligomerization tendency and shows
decreased DNA binding. Regardless of these differences, however,
both mutants share a similar sensitivity to oxidative stress. Hence,
our data support a role for oxidative stress in the pathogenesis of
FPLD, independent of prelamin A accumulation, and suggest that
disulphide-mediated oligomerization could add to the pathogenesis
of FPLD caused by mutations that introduce a cysteine in the C-ter-
minal globular domain of lamin A/C, such as R439C and R435C
(Fig. 2; A. van den Wijngaard, unpublished data).
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Fig. S1. Structural characterization of the R439C mutant A-type
lamin C-terminal globular domain (residues 411-553) by circular
dichroism (A, B) and NMR (C). (A) Evolution of the circular dichro-
ism spectrum of the R439C mutant Ig-like domain of A-type lamins
as a function of temperature. Curves corresponding to temperatures
from 10°C to 90°C are displayed according to the colour code at
the right of the diagram. (B) Molar residual ellipticity as a function
of the temperature for the wild-type and R439C mutant lamin
 globular domain was measured between 212 and 218 nm; the aver-
age measurement is shown. The figure shows that the denaturation
temperature of the R439C mutant is 58°C (blue graph). This 
value is close to the denaturation temperature of the wild-type
domain (about 62°C) (black graph). (C) Proton 1D NMR spectra
of the wild-type domain (black plot) and the R439C mutant lamin
globular domain (blue plot) recorded at 20°C. Analysis of the NMR
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